Cargando…
Clinical, pathological and treatment factors associated with the survival of patients with pulmonary sarcomatoid carcinoma
Pulmonary sarcomatoid carcinoma (PSC) is a group of five rare non-small cell lung cancer subtypes. In the present study, the clinical characteristics and outcomes of patients with PSC registered in the Surveillance, Epidemiology and End Results (SEER) database were investigated. For this purpose, da...
Autores principales: | Liang, Xiaohong, Cheng, Yinan, Yuan, Zijiang, Yan, Zhengping, Li, Quqing, Huang, Yuan, Feng, Gaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202303/ https://www.ncbi.nlm.nih.gov/pubmed/32382345 http://dx.doi.org/10.3892/ol.2020.11472 |
Ejemplares similares
-
Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK Inhibitor()
por: Chen, Xinru, et al.
Publicado: (2017) -
Clinical characteristics and prognostic factors of pulmonary sarcomatoid carcinoma
por: Zhao, Chenguang, et al.
Publicado: (2022) -
Survival analysis and nomogram for pulmonary sarcomatoid carcinoma: an SEER analysis and external validation
por: Wu, Weishuai, et al.
Publicado: (2023) -
Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinoma
por: Yu, Yingying, et al.
Publicado: (2022) -
Immunophenotyping of pulmonary sarcomatoid carcinoma
por: Ma, Yu, et al.
Publicado: (2022)